R. Barluzzi et al., ROLE OF THE CAPSULE IN MICROGLIAL CELL-CRYPTOCOCCUS NEOFORMANS INTERACTION - IMPAIRMENT OF ANTIFUNGAL ACTIVITY BUT NOT OF SECRETORY FUNCTIONS, MEDICAL MYCOLOGY, 36(4), 1998, pp. 189-197
Using two isogenic strains of Cryptococcus neoformans, we studied the
influence of the capsule in C. neoformans microglial-cell interaction.
We demonstrate that the acapsular mutant yeasts (CAP67) are more susc
eptible to phagocytosis and killing than encapsulated yeasts (B3501) b
y the murine microglial cells, BV-2. RT-PCR analysis showed that the p
attern of gene transcripts for tumour necrosis factor alpha (TNF-a), i
nterleukin (IL)-1 beta, IL-6, IL-12p40 and granulocyte macrophage colo
ny stimulating factor re:mains unchanged following BV-2 cell infection
with CAP67 or B3501 yeasts. Moreover, no induction of TNF-alpha secre
tion occurs in BV-2 cells infected with either B3501 or CAP67 yeasts o
r exposed to glucuronoxylomannan (GXM) or galactoxylomannan (GalXM). N
evertheless, lipopolysaccharide-induced TNF-alpha secretion is downreg
ulated by cell infection with B3501 or CAP67 yeasts or exposure to GXM
or GalXM. Overall, by means of a continuous cell line, it appears tha
t the C. neoformans capsule is detrimental to microglial cell antifung
al activity, while no effect can be attributed to the capsule as trend
of cytokine gene expression and TNF-alpha secretion.